What's Happening?
Johnson & Johnson has completed a clinical study evaluating the OTTAVA robotic surgical system for gastric-bypass procedures. The study involved 30 patients and met its primary safety and performance endpoints, with all procedures completed robotically.
The OTTAVA system is designed for multi-specialty soft-tissue surgeries and aims to integrate into existing hospital infrastructures. The company plans to use the study data to support an application for FDA De Novo classification, targeting a range of procedures in general surgery. The results were presented at the 2026 American Society for Metabolic and Bariatric Surgery Annual Meeting.
Why It's Important?
The successful completion of the OTTAVA study marks a significant advancement in robotic surgery, potentially expanding the accessibility and efficiency of complex procedures like gastric bypass. By integrating robotic systems into more operating rooms, hospitals can enhance surgical precision and patient outcomes. This development is particularly relevant in the context of rising obesity rates, as robotic-assisted bariatric surgeries offer effective long-term weight management solutions. The study's findings could lead to broader adoption of robotic systems in healthcare, improving surgical care and patient recovery times.
